Drugs / 10-valent pneumococcal vaccine GSK513026
last change Jan 2007 re-read 2 minutes ago

10-valent pneumococcal vaccine GSK513026

Vaccine

Developed for
streptococcal infection

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00327665 Comparator May 2006 → Jan 2007 streptococcal infection GlaxoSmithKline Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 10-valent pneumococcal vaccine GSK513026 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00327665
Modality Vaccine “10-valent Pneumococcal Conjugate VaccineNCT00327665
Route Intramuscular “Two-dose intramuscular injection” NCT00327665